FREE SHIPPING on all orders to continental US!

Kyolic

Kyolic KYOLIC - Liquid - Plain 2 oz + 60 Empty Caps Liquid+Empty Capsule

Kyolic

Kyolic KYOLIC - Liquid - Plain 2 oz + 60 Empty Caps Liquid+Empty Capsule

Barcode: 023542100212
Size: 2 oz + 60 Empty Caps
Form: Liquid+Empty Capsule

The garlic used to make KYOLIC Aged Garlic Extract is organically grown. Studies have suggested Aged Garlic Extract and its constituents may help to maintain healthy cholesterol levels,1-17 enhance circulation,18-21 support immune function,22-32 help fight stress and fatigue,33-40 and maintain health function of the liver41-48 and nerves.49-54 Aged Garlic has been shown to effectively kill the yeast Candida albicans in various studies.22,32,55 Veterinarian Gloria Dodd, D.V.M., has successfully used KYOLIC on many animals.


Liquid Kyolic
SUGGESTED USE
As a dietary supplement, take - teaspoon 300-600mg or 30-60 drops
one or two filled capsules size #00 with a meal twice daily.
Supplement Facts
Serving Size 1 capsule

Product Codes
100-20 2 fl. oz; no capsules
100-21 2 fl. oz; 60
gelatin cap
100-23 2 X 2 fl. oz; no capsules

 

Amount
per serving

%Daily Value

KYOLIC Aged Garlic Extract

1ml

300mg

**

Special Garlic Preparation      **Daily Value not established.
Contains water and residual alcohol from extraction.
 

Free of gluten, preservatives, sugar, sodium, milk, yeast, artificial colors and flavors.


    REFERENCES FOR KYOLIC LIQUID
    1. Abuirmeileh, N. et al. FASEB J. 5 6 8048, 1991.
    2. Efendy, J. et al. J. Vasc. Res. 33 S1 23, 1996.
    3. Efendy, J. et al. Atherosclerosis 132 37-42, 1997.
    4. Kawashima, Y. et al. Shinryo To Shinyaku Treat. New Med. 26 377-388, 1989.
    5. Lau, B. et al. Nutr. Res. 7 139-149, 1987.
    6. Liu, L. and Yeh, Y. 1999. FASEB 13 4 A556; #442.7.
    7. Liu, L. and Yeh, Y.Y. 1998. FASEB A261 1523.
    8. Qureshi, A. et al. First World Congress on the Health Significance of Garlic and Garlic Constituents FWC . Washington, D.C. August 28-30, p. 16, 1990.
    9. Steiner, M.  and Lin, R. 1994. J. Amer. Coll. Nutr 13 5 524.
    10. Steiner, M. et al. Am. J. Clin. Nutr. 64 866-870, 1996.
    11. Steiner, M. et al. J. Am. Coll. Nutr. 13 5 524, 1994.
    12. Steiner, M . et al. Shinyaku To Rinsho New Drug Clin. 45 3 456-466, 1996.
    13. Yeh, Y. et al. J. Am. Coll. Nutr. 14 5 545, 1995.
    14. Yeh, Y. et al. FWC. Washington, D.C. August 28-30, p. 37, 1990.
    15. Yeh, Y. et al. Lipids 29 3 189-193, 1994.
    16. Yeh, Y. Shinyaku To Rinsho New Drug Clin. 45 3 441-450, 1996.
    17. Yeh, Y. et al. In Food Factors for Cancer Prevention. Ohigashi, et al. eds. Springer-ag, Tokyo, p 226-230, 1997.
    18. Kikuchi, T. et al. Shinyaku To Rinsho Jpn. J. New Remedies Clin. 43 1 146-158, 1994.
    19. Okuhara, T. Jpn. Pharmacol. Therapeut. 22 8 3695-3701, 1994.
    20. Steiner, M. et al. J. Cardiovascular Pharmacol. 31 904-908, 1998.
    21. Yokoyama, K. et al. Oyo Yakuri Appl. Pharmacol. 36 301-308, 1988.
    22. Abdullah, T. et al. J. Oncology 21 52-53, 1989.
    23. Hirao, Y. et al. Phytother. Res. 1 161-164, 1987.
    24. Kandil, O. et al. Arch. AIDS Res 1 230-231, 1988.
    25. Kyo, E. et al. Phytomed. 5 4 259-267, 1998.
    26. Lau, B.H.S. et al. 1991. Molecular Biother. 3 103-107.
    27. Lau, B.H.S. Int. Clin. Nutr. Rev. 9 27-31, 1989.
    28. Morioka, N. et al. Cancer Immunol. Immunother. 37 316-322, 1993.
    29. Nagai, K. 1973. Kansenshogaku-Zasshi 47 9 321-325.
    30. Reeve, V. et al. Photochem. Photobiol. 58 6 813-817, 1993.
    31. Riggs, D. et al. Cancer 79 1987-1994, 1997.
    32. Tadi, P.P. et al. Int. Clin. Nutr. Rev. 10 423-429, 1990.
    33. Hasegawa, Y. et al. Shinyaku To Rinsho Jpn. J. New Remedies Clin. 32 365-376, 1983.
    34. Kawashima, H. et al. Shinryou To Shinyaku Treat. New Med. 22 12 3012-3024, 1985.
    35. Kawashima, Y. et al. Kiso To Rinsho Preclin. Clin. Reports 20 16 8229-8245, 1984.
    36. Miyoshi, A. et al. Shinryou To Shinyaku Treat. New Med. 21 1806-1820, 1984.
    37. Okada, K. and Miyagaki, H. Kiso To Rinsho Preclin. Clin. Reports 17 2173-2183, 1983.
    38. Takasugi, N. et al. Oyo Yakuri Appl. Pharmacol. 31 967-976, 1986.
    39. Takasugi, N. et al. Oyo Yakuri Appl. Pharmacol. 28 991-1002, 1984.
    40. Yokoyama, K. et al. Oyo Yakuri Appl. Pharmacol. 31 977-984, 1986.
    41. Horie, T. et al. Planta Med. 55 506-508, 1989.
    42. Horie, T. et al. Planta Med. 58 468-469, 1992.
    43. Nakagawa, S. et al. Hiroshima J. Med. Sci. 34 303-309, 1985.
    44. Nakagawa, S. et al. Phytother. Res. 1 1-4, 1988.
    45. Sumioka, I. et al. Jpn. J. Pharmacol. 78 199-207, 1998. 
    46. Tadi, P. et al. Nutr. Cancer 15 87-95, 1991
    47. Wang, B. et al. Toxicology 126 213-222, 1998.
    48. Wang, B. et al. Toxicology 132 215-225, 1999.
    49. Welch, C. et al. Cancer Lett. 63 211-219, 1992.
    50. Gwebu, E. et al. Soc. Neurosci. 24 2 #571.11, 1998.
    51. Moriguchi, T. et al. Neurochem. Res. 22 12 1449-1452, 1997.
    52. Moriguchi, T. et al. Phytother. Res. 10 468-472, 1996.
    53. Nishiyama, N. et al. Int. Acad. Biomed. Drug Res. Basel. Karger. 11 253-258, 1996.
    54. Saito, H. et al. Ch. 16. In Nutraceuticals Designer Foods III Garlic, Soy and Licorice. Paul P. Lanchance ed. . Food & Nutrition Press, Trumbell, CT, pp. 153-161, 1997.
    55. Matsuura, H. et al. Chem. Pharm. Bull. 36 3659-3663, 1988.


NOTICE:

International Customers:Unfortunately we are not able to ship Kyolic products internationally. We sincerely apologize for any inconvenience.



Subscribe